"This is the best use of my time to remain current with what is going on in the industry."
There is increased scrutiny by regulatory agencies on the collection of investigator’s signature as evidence of the overall oversight on the eCRF data reported to the sponsor. Due to different interpretation on the timing and frequency for the collection of the investigator’ssignature, an eCF Task Force has been formed to identify best practices that are based on the compliance to regulatory requirements and on risks such as reputation, credibility, legal liability of the data being used by the sponsor. The intent of this document is to provide a framework for individuals’ risk‐based decisions and best practices for implementing solutions for investigators’ signature collection on data reported to sponsor.
eCF Webinar September "ICH E6 (R3) Annex 2"
Join us for a discussion on CH E6 (R3) Annex 2 and its role in modernizing GCP to better reflect the evolving landscape of clinical research on Wednesday, September 9, 2026.
Americas Autumn Workshop, October 13-15, 2026, Bloomington IL, USA, hosted by GenInvo
APAC/Hybrid Autumn Workshop, October 22-23, 2026, Shanghai, China, hosted by Clario
Europe/Hybrid Autumn Workshop, October 27-29, 2026, Zurich, Switzerland, hosted by BSI Software